Market Trends – Technological Advancements
— Emerging research
VANCOUVER, BC, USA, May 23, 2022 /EINPresswire.com/ —
The global assisted reproductive technologies market size is expected to reach USD 54.75 billion with a stable revenue CAGR of 9.7% in 2028, according to the latest analysis from Emergen Research.
Assisted Reproductive Technologies (ART) Market revenue growth is driven by the growing popularity of in vitro fertilization (IVF) (with or without intracytoplasmic sperm injection (ICSI)) and artificial insemination, among other technologies. Infertility is a multi-faceted problem involving social, cultural and economic implications, which can reach threatening proportions in countries with lower fertility rates.
According to statistics published by the WHO, approximately 48 million couples and 186 million people live with infertility worldwide. The increasing incidence of ovulation problems with irregular or no periods is a common cause of infertility in women. Increased awareness of various fertility treatments among the younger generation and more women opting for such fertility treatments are driving the growth of the market.
Get a sample report @ https://www.emergenresearch.com/request-sample/165
The study offers comprehensive coverage of the qualitative and quantitative analysis of the Assisted Reproductive Technology (ART) market along with crucial statistical data of the Assisted Reproductive Technology (ART) market. The research study provides historical data and offers an accurate estimation of the forecast till 2028. The report also introduces the established and emerging players of the market, covering business overview, product portfolio, strategic alliances and business expansion strategies.
Some of the key players in the market report include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd.
In June 2020, Ferring Pharmaceuticals announced a two-year collaboration with Igenomix for innovative disease mechanism research and target discovery in conditions associated with infertility and pregnancy, such as preeclampsia, to develop approaches breakthrough diagnostics and therapeutics to meet strong unmet demand. A new center in Boston has been created which will bring together experts from both companies and the objective is to study molecular structures, develop functional genomic systems and create tools to study embryo implantation, among others.
The revenue of frozen non-donor segment is expected to register a significantly rapid growth rate over the forecast period due to its established reliability and higher success rate for pregnancy. The cost of the procedure is lower than cycles using fresh embryos and eggs. A frozen transfer is much simpler for the reproductive endocrinologist and the patient. This procedure is also less mentally and physically stressful on a woman’s body.
Ask for a discount on the report @ https://www.emergenresearch.com/request-discount/165
The report is an investigative study of technological developments and product advancements, along with regional analysis for each product and application offered in the market. The basic objective of the report is to provide an insight into how the Assisted Reproductive Technology (ART) industry works. It provides an accurate and strategic view of the market with an in-depth assessment of market segments and sub-segments. It offers a panoramic view of the industry to provide a deeper understanding of the global industry.
Emergen Research has segmented the global assisted reproductive technology market based on procedure, technology, end-use, and region:
Procedural Outlook (Revenue, USD Billion; 2018-2028)
Technology Outlook (Revenue, USD Billion; 2018-2028)
In Vitro Fertilization (IVF)
In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI)
In vitro fertilization (IVF) without intracytoplasmic sperm injection (ICSI)
Frozen Embryo Transfer (FET)
End-Use Outlook (Revenue, USD Billion; 2018-2028)
The full regional analysis covers:
North America (United States, Canada, Mexico
Europe (UK, Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)
The report offers a comprehensive understanding of the impact of the COVID-19 pandemic on the overall market growth and expansion. COVID-19 has affected the global economy by interfering with production and demand, causing market disruptions and inducing financial instability.
Request report customization @ https://www.emergenresearch.com/request-for-customization/165
Key Points of the Assisted Reproductive Technology (ART) Market:
Extensive Assisted Reproductive Technology (ART) Market Analysis Coverage
Key information on the regional breakdown of the industry in key geographies
Sweeping insights into vital market trends; current and emerging trends, and factors influencing market growth
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Assisted Reproductive Technology (ART) Market
Comprehensive data on major manufacturers and suppliers of Assisted Reproductive Technology (ART) Market
Thank you for reading our report. Report customization is available. To find out more, please contact us and our team will ensure the report is customized to your needs.
Take a look at our related reports:
Aircraft Fuel Systems Market
Skin Regeneration Models Market
Smart Product Vending Machine Market
Maritime Autonomous Surface Vessels Market
Energy and Utilities Analytics Market
computer aided design market
Streaming Media Devices Market
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.